You are here

Home » Content

ANTICONVULSANT ACTIVITY OF ETHANOLIC EXTRACT OF ABRUS PRECATORIUS LEAVES

Journal Name:

  • Advance Research in Pharmaceuticals and Biologicals

Publication Year:

  • 2012

Key Words:

Author Name
Abstract (2. Language): 
Abrus precatorius which is commonly called as Indian licorice has been used for many centuries by traditional healers of Tanzania for the treatment of convulsions. The present work has been carried out to evaluate the anticonvulsant activity of the ethanolic extract (EE) of A. precatorius leaves against Pentylenetetrazole (PTZ), Picrotoxin and Maximal electroshock (MES) induced convulsions at the doses 100, 200, 400 mg/kg. Diazepam (5mg/kg, i.p.) and Phenytoin (25mg/kg i.p) act as reference standards. At the medium dose and high dose, Abrus precatorius extract significantly delayed the onset of clonic seizures induced by PTZ and Picrotoxin and reduced the duration of hind limb extension in MES induced convulsion test. The phytochemical investigation of the leaves of A.precatorius revealed the presence of flavonoids, triterpenoids, saponins, reducing sugars, phenolic compounds and glycosides. The results obtained indicate that the ethanolic extract of A. precatorius may help to control grand mal and petitmal epilepsy.
Bookmark/Search this post with
FULL TEXT (PDF): 
PDF icon arastrmx_160852_2_pp_53-61.pdf
  • 1
53-61
  • English

REFERENCES

References: 

1. K. R. Susanata, M. K. Durga. A
review on antiepileptic agents.
Current research and future
prospectus on conventional and
traditional drugs, International
Journal of Pharmaceutical Sciences
Review and Research, Volume 3,
Issue 2, July – August 2010, Article
004: 19-23
2. K. D. Tripathi, Essentials of Medical
Pharmacology, 6th ed, Jaypee, New
Delhi, 2008, 401‐405.
3. A. Arzimanoglou, E. Hirsh, A.
Nehlig, P. Castelnau, P. Gressens, d
Vasconcelos Ap. Epilepsy and
neuroprotection: An illustrated
review, Epileptic Disord, 3: 173–83
(2002).
4. H. P. Rang, M. M. Dale, J. M. Rittet,
P. K. Moore. Pharmacology, 5th ed,
Churchill Livingstone, New Delhi,
2005, 550‐554
5. D. S. Reddy. Pharmacotherapy of
catamenial epilepsy, Indian Journal
of Pharmacol 37:288-293 (2005).
6. R. Duraisami, D. Srinivasan, S.
Ramaswamy. Anticonvulsant activity
of bioflavonoid gossypin, Bangladesh
J Pharmacol 4: 51‐54 (2009).
7. R. H. Mattson. Drug treatment of
partial epilepsy, Adv Neurol 57:
643‐650 (1992).
8. Y. K. Gupta, J. Malhotra.
Adenosinergic system as an
endogenous anticonvulsant
mechanism, J Physiol and Pharmacol
41: 329‐343 (1997).
9. K. M. Nadkarni. Indian Materica
Medica, Bombay, Popular Prakashan
Pvt. Ltd. Vol 1, 1976, pp. 5-6.
10. M. J. Moshi, G. A. Kagashe, Z. H.
Mbwambo. Plants used to treat
epilepsy by Tanzanian traditional
healers, J Ethnopharmacol. 28: 97(2):
327-36 (2005).
11. K. R. Khandelwal. Practical
Pharmacognosy. Pune, Nirali
Prakashan, 2010, pp. 23: 15‐23.
12. C. K. Kokate. Practical
Pharmacognosy. 4th ed. New Delhi,
Vallabh Prakashan, 1994, pp.
110‐116.
13. OCED 423 guidelines. OCED
guidelines for testing animals (2001);
Dec l7:1-14.
14. H. Gerhard Vogel (Ed.). Drug
Discovery and Evaluation,
Pharmacological assays, 2nd ed. New
York: Springer Verlag Heidelberg;
2002, pp. 422-424.
15. J. O. McNamara. Drugs effective in
the therapy of the Epilepsies, In;
Goodman and Gilman’s. The
pharmacological basis of
ASHOK et al., ARPB, 2012; Vol 2 (1) ISSN 2250-0774
(Research Article)
www.arpb.info Page 61
therapeutics, 10th edition, (Hardman
JG, Limbird LE, Gilman AG), New
York, McGraw-Hill publishers, 2001,
pp. 521- 47.
16. R. Ramanjaneyulu, M. K. Ticku.
Interactions of
pentamethylenetetrazole and tetrazole
analogues with the picrotoxin site of
the benzodiazepine-GABA receptor
ionophore complex, Euro J
Pharmacol 1998, 347: 337-45.
17. P. Khosla, P. Pandhi. Anticonvulsant
effect of nimodipine alone and in
combination with diazepam on PTZ
induced convulsions, Ind J
Pharmacol 2001, 33: 208-11.
18. L. R. Helen, A. M. Charles, F. M.
Keith. Differential effects of
phenytoin and sodium valproate on
seizure-induced changes in gammaaminobutyric
acid and glutamate
release in vivo. Euro J Pharmacol
1995, 294: 541-6.
19. P. M. J. Glue, A. Costello, A. Pert,
Mele, D. J. Nutt. Regional
neurotransmitter responses after acute
and chronic electroconvulsive shock,
Psychopharmacol 100:60 (1990).
20. H. P. Rang, M. M. Dale and J. M.
Ritter. Pharmacology, Churchill
Livingstone Publishers, United
Kingdom, 2000, 4:604-613.
21. M. A. Ragwaski, R. J. Porter.
Antiepileptic drugs and
pharmacological mechanisms and
clinical efficacy with consideration of
promising development stage
compounds, Pharmacol Rev 42: 223-
86 (1995).
22. R. L. Macdonald, K. M. Kelly.
Antiepileptic drug mechanisms of
action, Epilepsia 36: S2-12 (1995).

Thank you for copying data from http://www.arastirmax.com